open access

Vol 3, No 1 (2018)
Original article
Published online: 2018-03-20
Get Citation

The reliability of the specimens for neuropathological evaluation in pituitary adenomas treated via transphenoidal route

Borys M. Kwinta1, Roger M. Krzyżewski1, Kornelia Kliś1, Ewelina Grzywna1, Krzysztof Stachura1, Dariusz Adamek2
·
Medical Research Journal 2018;3(1):23-27.
Affiliations
  1. Department of Neurosurgery and Neurotraumatology, Jagiellonian University Medical College, Kraków, Poland, Botaniczna 3, 31-501 Kraków, Poland
  2. Department of Neuropathology, Jagiellonian University Medical College, Kraków, Poland, Botaniczna 3, 31-501 Kraków, Poland

open access

Vol 3, No 1 (2018)
ORIGINAL ARTICLES
Published online: 2018-03-20

Abstract

Introduction: There are some discrepancies between immunohistochemical staining results and clinical picture of pituitary adenomas. Such a discordance may be caused by multiple factors. The problem of securing the histopathological material during the transsphenoidal pituitary surgery and its reliability for neuropathological evaluation deserves a special attention. The surgical biopsy does not always meet the criteria required for a immunohistochemical staining and sometimes not even for the routine histopatho-logical examination.

Aims: To determine the frequency of unreliable material for histopathological examination and factors influencing the reliability of histopathological specimens after surgery for pituitary adenomas.

Material and methods: The hematoxylin and eosin sections were examined in detail. with a special attention to the presence of incidental findings, i.e. admixture of normal pituitary gland tissue, signs of hemorrhage, necrosis, thermal artifacts, inflammatory changes, respiratory epithelium, vessels or cholesterol granuloma. The impact of incidental findings on further immunohistochemical analysis was investigated. The relationship between the magnetic resonance imaging (MRI)- determined tumor size and the area of histopathological specimen was assessed and considered as a reliability parameter.

Results: The unreliable material was estimated at the level of 11.8%. It was assessed that hemorrhages, neurohypophysis, necrosis and quantity of collected histopathological material had the statistically sig-nificant impact on the reliability of the histopathological material. The statistical analysis did not show any relation between the reliability of the histopathological material and the MRI-determined volume of the tumor. Conclusions: The presence of some additional tissue elements and artifacts in the histopathological specimen makes the immunohistochemical evaluation difficult or even impossible. However, this problem is related to a relatively low percentage of cases, mainly small tumors.

Abstract

Introduction: There are some discrepancies between immunohistochemical staining results and clinical picture of pituitary adenomas. Such a discordance may be caused by multiple factors. The problem of securing the histopathological material during the transsphenoidal pituitary surgery and its reliability for neuropathological evaluation deserves a special attention. The surgical biopsy does not always meet the criteria required for a immunohistochemical staining and sometimes not even for the routine histopatho-logical examination.

Aims: To determine the frequency of unreliable material for histopathological examination and factors influencing the reliability of histopathological specimens after surgery for pituitary adenomas.

Material and methods: The hematoxylin and eosin sections were examined in detail. with a special attention to the presence of incidental findings, i.e. admixture of normal pituitary gland tissue, signs of hemorrhage, necrosis, thermal artifacts, inflammatory changes, respiratory epithelium, vessels or cholesterol granuloma. The impact of incidental findings on further immunohistochemical analysis was investigated. The relationship between the magnetic resonance imaging (MRI)- determined tumor size and the area of histopathological specimen was assessed and considered as a reliability parameter.

Results: The unreliable material was estimated at the level of 11.8%. It was assessed that hemorrhages, neurohypophysis, necrosis and quantity of collected histopathological material had the statistically sig-nificant impact on the reliability of the histopathological material. The statistical analysis did not show any relation between the reliability of the histopathological material and the MRI-determined volume of the tumor. Conclusions: The presence of some additional tissue elements and artifacts in the histopathological specimen makes the immunohistochemical evaluation difficult or even impossible. However, this problem is related to a relatively low percentage of cases, mainly small tumors.

Get Citation

Keywords

transsphenoidal pituitary surgery, histopathological specimen, reliability

About this article
Title

The reliability of the specimens for neuropathological evaluation in pituitary adenomas treated via transphenoidal route

Journal

Medical Research Journal

Issue

Vol 3, No 1 (2018)

Article type

Original article

Pages

23-27

Published online

2018-03-20

Page views

868

Article views/downloads

772

DOI

10.5603/MRJ.2018.0004

Bibliographic record

Medical Research Journal 2018;3(1):23-27.

Keywords

transsphenoidal pituitary surgery
histopathological specimen
reliability

Authors

Borys M. Kwinta
Roger M. Krzyżewski
Kornelia Kliś
Ewelina Grzywna
Krzysztof Stachura
Dariusz Adamek

References (23)
  1. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001; 8(4): 287–305.
  2. Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006; 65(2): 265–273.
  3. Gsponer J, De Tribolet N, Déruaz JP, et al. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore). 1999; 78(4): 236–269.
  4. Dorn A, Nyström S, Müller M, et al. Immunocytochemical characterisation of human pituitary adenomas. Zentralbl Neurochir. 1985; 46(3): 188–194.
  5. Kleinschmidt-DeMasters BK. Subtyping does matter in pituitary adenomas. Acta Neuropathol. 2006; 111(1): 84–85.
  6. Nosé V, Grossman A, Mete O. Lactotroph adenoma. In: Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. WHO Classification of Tumours of Endocrine Organs. 4th edition. IARC Press, Lyon. ; 2017: 24–27.
  7. Hamid Z, Mrak R, Ijaz M, et al. Sensitivity and Specificity of Immunohistochemistry in Pituitary Adenomas. The Endocrinologist. 2009; 19(1): 38–43.
  8. Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology. 2006; 83(3-4): 179–188.
  9. Horvath E, Scheithauer B, Kovacs K, et al. Hypothalamus and pituitary. In: Graham D, Lantos P, editors. Greenfield’s Neuropathology. 7th edition. Edward Arnold, Londyn. ; 2000: 983–1062.
  10. Kontogeorgos G, Kovacs K, Lloyd RV, et al. Plurihormonal and double adenomas. In:, Osamura RY, Klöppel G, Rosai J, editors. WHO Classification of Tumours of Endocrine Organs. 4th edition. IARC Press, Lyon. ; 2017: 39–40.
  11. Pawlikowski M, Kunert-Radek J, Radek M. Plurihormonality of pituitary adenomas in light of immunohistochemical studies. Endokrynol Pol. 2010; 61(1): 63–66.
  12. Saeger W, Lüdecke DK, Buchfelder M, et al. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol. 2007; 156(2): 203–216.
  13. Sano T. Comments on the WHO histological classification of pituitary tumors. Acta Neuropathol. 2006; 111(1): 82–83.
  14. Matsuo T, Mori H, Nishimura Y, et al. Quantification of immunohistochemistry using an image analyser: correlation with hormone concentrations in pituitary adenomas. Histochem J. 1995; 27(12): 989–996.
  15. Scheithauer B, Kovacs K, Horvath E, et al. Pathology of the Pituitary and Sellar Region. Practical Surgical Neuropathology. 2010: 371–416.
  16. Maksymowicz M. Ocena przydatności mikroskopii elektronowej i immunocytochemii na poziomie ultrastrukturalnym w diagnostyce klasyfikacji gruczolaków przysadki [dissertation]. Medical University of Warsaw. ; 2002.
  17. DI CHIRO G, NELSON KB. The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med. 1962; 87: 989–1008.
  18. Yamada S, Ohyama K, Taguchi M, et al. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery. 2007; 61(3): 580–4; discussion 584.
  19. Osamura RY, Grossman A, Korbonits M, et al. Pituitary adenoma. In: Lloyd RV, , Klöppel G, Rosai J, editors. WHO Classification of Tumours of Endocrine Organs. 4th edition. IARC Press, Lyon. ; 2017: 13.
  20. Perry A, Scheithauer BW. Commentary: Classification and grading of pituitary tumors. Observations of two working neuropathologists. Acta Neuropathol. 2006; 111(1): 68–70.
  21. Lloyd RV, Kovacs K, Young Jr. Pituitary tumors: Introduction. In: Delellis RA, , Heitz PU, Eng C, editors. World Health Organisation Classification of Tumours: Pathology & Genetics – Tumours of Endocrine Organs. Lyon: IARC Press. ; 2004: 10–13.
  22. Knosp E, Krisch K, Schmidbauer M, et al. [Immunologic hormone detection in hypophyseal adenomas: correlation of serum hormone findings with immunocytochemical hormone levels in tumor tissue]. Wien Klin Wochenschr. 1988; 100(10): 322–325.
  23. Saeger W. Current pathological classification of pituitary adenomas. Acta Neurochir Suppl. 1996; 65(2): 1–3.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl